The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Limited Uptake of Hepatitis C Treatment Among Injection Drug Users
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Revisiting the Behavioral Model and Access to Medical Care: Does it Matter?
Andersen, R. M. (1995) · Journal of Health and Social Behavior · doi:10.2307/2137284 · Cited by 9,831
Centers for Disease Control and Prevention
(2007) · Encyclopedia of Measurement and Statistics · doi:10.4135/9781412952644.n74 · Cited by 6,444
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Gonçales, F. L., Häussinger, D., Diago, M., Carosi, G., Dhumeaux, D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020047 · Cited by 6,389
Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M., Reindollar, R., Goodman, Z. D., Koury, K., Ling, M.-H., & Albrecht, J. K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06102-5 · Cited by 6,029
Morbidity and mortality weekly report
(1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89440-5 · Cited by 4,684
Castéra, L., Vergniol, J., Foucher, J., Le Bail, B., Chanteloup, E., Haaser, M., Darriet, M., Couzigou, P., & de Lédinghen, V. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.018 · Cited by 2,487
Surveillance for waterborne-disease outbreaks--United States, 1993-1994.
Kramer, M. H., Herwaldt, B. L., Craun, G. F., Calderon, R. L., & Juranek, D. D. (1996) · PubMed · Cited by 2,152
Diagnosis, management, and treatment of hepatitis C†
Strader, D. B., Wright, T., Thomas, D. L., & Seeff, L. B. (2004) · Hepatology · doi:10.1002/hep.20119 · Cited by 1,709
Self-citationImbert-Bismut, F., Ratziu, V., Pieroni, L., Charlotte, F., Benhamou, Y., & Poynard, T. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04258-6 · Cited by 1,433
Torriani, F. J., Rodriguez-Torres, M., Rockstroh, J. K., Lissen, E., Gonzalez-García, J., Lazzarin, A., Carosi, G., Sasadeusz, J., Katlama, C., Montaner, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040842 · Cited by 1,233
The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors
Thomas, D. L., Astemborski, J., Rai, R. M., Anania, F. A., Schaeffer, M., Galai, N., Nolt, K., Nelson, K. E., Strathdee, S. A., Johnson, L., et al. (2000) · JAMA · doi:10.1001/jama.284.4.450 · Cited by 1,073
Self-citationChung, R. T., Andersen, J., Volberding, P., Robbins, G. K., Liu, T., Sherman, K. E., Peters, M. G., Koziel, M. J., Bhan, A. K., Alston, B., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032653 · Cited by 875
(1997) · Hepatology · doi:10.1002/hep.510260701 · Cited by 569
Muir, A. J., Bornstein, J. D., & Killenberg, P. G. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032502 · Cited by 541
NIH Consensus Statement on Management of Hepatitis C: 2002.
(2002) · PubMed · Cited by 536
Persistence of Viremia and the Importance of Long–Term Follow–Up After Acute Hepatitis C Infection
Villano, S. A., Vlahov, D., Nelson, K. E., Cohn, S., & Thomas, D. L. (1999) · Hepatology · doi:10.1002/hep.510290311 · Cited by 475
Self-citationProtection against persistence of hepatitis C
Mehta, S. H., Cox, A., Hoover, D. R., Wang, X.-H., Mao, Q., Ray, S., Strathdee, S. A., Vlahov, D., & Thomas, D. L. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08435-0 · Cited by 440
Self-citationCorrelates of Hepatitis C Virus Infections among Injection Drug Users
Thomas, D. L., Vlahov, D., Solomon, L., Cohn, S., Taylor, E., Garfein, R., & Nelson, K. E. (1995) · Medicine · doi:10.1097/00005792-199507000-00005 · Cited by 362
Self-citationVlahov, D., US Department of Health and Human Services; National Institute on Drug Abuse, Anthony, J. C., Munoz, A., Margolick, J., Nelson, K. E., Celentano, D. D., Solomon, L., & Polk, B. F. (1991) · PsycEXTRA Dataset · doi:10.1037/e496262006-006 · Cited by 336
Self-citationTreatment of Hepatitis C Infection in Injection Drug Users
Backmund, M., Meyer, K., Von Zielonka, M., & Eichenlaub, D. (2001) · Hepatology · doi:10.1053/jhep.2001.25882 · Cited by 256
Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland
Villano, S. A., Vlahov, D., Nelson, K. E., Lyles, C. M., Cohn, S., & Thomas, D. L. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.12.3274-3277.1997 · Cited by 227
Self-citationBarriers to the treatment of hepatitis C: Patient, provider, and system factors
Morrill, J. A., Shrestha, M., & Grant, R. W. (2005) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.0161.x · Cited by 180
van Ameijden, E. J. C., Van Den Hoek, J. A. R., Mientjes, G. H. C., & Coutinho, R. A. (1993) · European Journal of Epidemiology · doi:10.1007/bf00146260 · Cited by 161
Mauss, S., Berger, F., Goelz, J., Jacob, B., & Schmutz, G. (2004) · Hepatology · doi:10.1002/hep.20279 · Cited by 161
Hepatitis C virus in intravenous drug users
Bell, J. R., Batey, R. G., Farrell, G. C., Crewe, E. B., Cunningham, A. L., & Byth, K. (1990) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1990.tb136900.x · Cited by 160
Fleming, C. A., Craven, D. E., Thornton, D., Tumilty, S., & Nunes, D. (2003) · Clinical Infectious Diseases · doi:10.1086/344907 · Cited by 150
Doab, A., Treloar, C., & Dore, G. J. (2005) · Clinical Infectious Diseases · doi:10.1086/427446 · Cited by 144
Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic
Mehta, S. H., Lucas, G. M., Mirel, L. B., Torbenson, M. S., Higgins, Y., Moore, R. D., Thomas, D. L., & Sulkowski, M. (2006) · AIDS · doi:10.1097/qad.0b013e32801086da · Cited by 133
Self-citationTreatment of Chronic Hepatitis C in Active Drug Users
Davis, G. L., & Rodrigue, J. R. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450312 · Cited by 128
Sylvestre, D. L., Litwin, A. H., Clements, B. J., & Gourevitch, M. N. (2005) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2005.06.002 · Cited by 109
Strathdee, S. A., Latka, M. H., Campbell, J. V., O’Driscoll, P. T., Golub, E. T., Kapadia, F., Pollini, R. A., Garfein, R. S., Thomas, D. L., Hagan, H., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/427445 · Cited by 105
Self-citationResponse To Treatment of Hepatitis C in Individuals With A Recent History of Intravenous Drug Abuse
Thiel, D. H. V., Anantharaju, A., & Creech, S. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07702.x · Cited by 98
The impact of injecting drug use status on hepatitis C-related referral and treatment
Stoove, M. A., Gifford, S., & Dore, G. J. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.07.002 · Cited by 91
Broers, B., Helbling, B., François, A., et al. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.11.018 · Cited by 87
Mehta, S. H., Thomas, D. L., Sulkowski, M., Safaein, M., Vlahov, D., & Strathdee, S. A. (2005) · AIDS · doi:10.1097/01.aids.0000192088.72055.90 · Cited by 76
Self-citationSeverity and correlates of liver disease in hepatitis C virus-infected injection drug users
Rai, R., Wilson, L. E., Astemborski, J. A., Anania, F. A., Torbenson, M. S., Spoler, C., Vlahov, D., Strathdee, S. A., Boitnott, J., Nelson, K. E., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.33151 · Cited by 73
Self-citationTreatment for Hepatitis C Virus Infection among Current Injection Drug Users in Australia
Matthews, G. V., Kronborg, I. J., & Dore, G. J. (2005) · Clinical Infectious Diseases · doi:10.1086/427448 · Cited by 55
Fishbein, D. A., Lo, Y., Reinus, J. F., Gourevitch, M. N., & Klein, R. S. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000131932.21612.49 · Cited by 47
Delivering Care to Injection Drug Users Coinfected with HIV and Hepatitis C Virus
Taylor, L. E. (2005) · Clinical Infectious Diseases · doi:10.1086/427453 · Cited by 44
Approaching Treatment for Hepatitis C Virus Infection in Substance Users
Sylvestre, D. L. (2005) · Clinical Infectious Diseases · doi:10.1086/429501 · Cited by 24
Kresina, T. F., Eldred, L. J., Bruce, R. D., & Francis, H. L. (2005) · AIDS · doi:10.1097/01.aids.0000192093.46506.e5 · Cited by 23
Cited by
Harris, M., & Rhodes, T. (2013) · Harm Reduction Journal · doi:10.1186/1477-7517-10-7 · Cited by 260
Linas, B. P., Barter, D. M., Morgan, J. R., Pho, M. T., Leff, J. A., Schackman, B. R., Horsburgh, C. R., Assoumou, S. A., Salomon, J. A., Weinstein, M. C., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1313 · Cited by 101
“Sofosbuvir changed the landscape of HCV therapy, given that concerns about interferon-related toxicity has historically limited provider and patient enthusiasm for HCV treatment (5).”
Chronic hepatitis C and antiviral treatment regimens: Where can psychology contribute?
Evon, D. M., Golin, C. E., Fried, M. W., & Keefe, F. J. (2013) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0029030 · Cited by 32
Metadata
- Authors
- Mehta, S. H., Genberg, B. L., Astemborski, J., Kavasery, R., Kirk, G. D., Vlahov, D., Strathdee, S. A., & Thomas, D. L.
- Venue
- Journal of Community Health
- Published
- 2007-12-29
- Volume
- 33
- Issue
- 3
- Pages
- 126-133
- ISSN
- 0094-5145 (ISSN-L)
- 1573-3610
- OpenAlex
- W2044421611
- Cited by
- 327
- References
- 42
- FWCI
- 9.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.